US 11572359
PARP/PI3K double-target inhibit containing pyridopyrimidine structure
granted A61KA61K31/5377A61P
Quick answer
US patent 11572359 (PARP/PI3K double-target inhibit containing pyridopyrimidine structure) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/5377, A61P, A61P35/00